Mechanisms of ovarian aging in women: a review

X Wang, L Wang, W Xiang - Journal of Ovarian Research, 2023 - Springer
Ovarian aging is a natural and physiological aging process characterized by loss of quantity
and quality of oocyte or follicular pool. As it is generally accepted that women are born with a …

A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome

MA Abdalla, H Deshmukh, S Atkin… - … in endocrinology and …, 2020 - journals.sagepub.com
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of
reproductive age. Metabolic sequelae associated with PCOS range from insulin resistance …

MiR-93-5p promotes granulosa cell apoptosis and ferroptosis by the NF-kB signaling pathway in polycystic ovary syndrome

W Tan, F Dai, D Yang, Z Deng, R Gu, X Zhao… - Frontiers in …, 2022 - frontiersin.org
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in
women of reproductive age. miR-93-5p has been reported to be elevated in granulosa cells …

miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): a review

M Abdalla, H Deshmukh, SL Atkin, T Sathyapalan - Life Sciences, 2020 - Elsevier
Polycystic ovary syndrome (PCOS) is the most prevalent endocrine disorder in females of
the reproductive age. PCOS is commonly manifested as ovulatory dysfunction, clinical and …

Exosomal miR-143-3p derived from follicular fluid promotes granulosa cell apoptosis by targeting BMPR1A in polycystic ovary syndrome

Y Zhao, S Pan, Y Li, X Wu - Scientific reports, 2022 - nature.com
Polycystic ovary syndrome (PCOS) is an endocrine disorder that occurs in women of
reproductive age. Anovulation caused by abnormal follicular development is still the main …

Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: A systematic review

MV Moreira, E Vale-Fernandes, IC Albergaria… - Reviews in Endocrine …, 2023 - Springer
Polycystic ovary syndrome (PCOS) is recognized as one of the most prevalent
endocrinopathy in women at reproductive age. As affected women tend to have poorer …

Downregulating lncRNA NEAT1 induces proliferation and represses apoptosis of ovarian granulosa cells in polycystic ovary syndrome via microRNA-381/IGF1 axis

J Zhen, J Li, X Li, X Wang, Y Xiao, Z Sun… - Journal of Biomedical …, 2021 - Springer
Objective Researchers have revealed the combined functions of long noncoding RNAs
(lncRNAs) and microRNA (miRNAs) in polycystic ovary syndrome (PCOS). This study aimed …

The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside—A Systematic Literature Review

SG Vitale, AM Fulghesu, M Mikuš, R Watrowski… - Biomedicines, 2022 - mdpi.com
MicroRNAs (miRNAs) are small, non-coding RNAs that are essential for the regulation of
post-transcriptional gene expression during tissue development and differentiation. They are …

Updates in diagnosing polycystic ovary syndrome-related infertility

H Haddad-Filho, JAG Tosatti, FM Vale… - Expert Review of …, 2023 - Taylor & Francis
Introduction Polycystic ovary syndrome (PCOS) is a condition that affects approximately 13%
of reproductive age women and is characterized by androgen excess, menstrual irregularity …

microRNAs and long non‐coding RNAs as biomarkers for polycystic ovary syndrome

M Tamaddon, M Azimzadeh… - Journal of cellular and …, 2022 - Wiley Online Library
Polycystic ovary syndrome (PCOS) is known as the most common metabolic/endocrine
disorder among women of reproductive age. Its complicated causality assessment and …